Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8895616 Composition and method for treating neurological disease

Patent 8895616 was granted and assigned to Adamas Pharmaceuticals, Inc. on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88956160

Patent Inventor Names

Gregory T. Went0

Laurence R. Meyerson0

Seth Porter0

Timothy J. Fultz0

Timothy S. Burkoth0

Date of Patent

November 25, 2014

Patent Application Number

144512420

Date Filed

August 4, 2014

Patent Citations Received

‌

US Patent 11903908 Methods of administering amantadine

‌

US Patent 11833121 Composition and method for treating neurological disease

‌

US Patent 11890261 Composition and method for treating neurological disease

Patent Primary Examiner

‌

Paul Zarek

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8895616 Composition and method for treating neurological disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API